Today: 20 December 2025
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Cellebrite (CLBT) Soars on Q3 2025 Earnings Beat, Raised Guidance and Fresh Analyst Upgrades

Cellebrite (CLBT) Soars on Q3 2025 Earnings Beat, Raised Guidance and Fresh Analyst Upgrades

Digital intelligence specialist Cellebrite DI Ltd. (Nasdaq: CLBT) is jumping on Thursday, November 13, 2025, after posting stronger‑than‑expected third‑quarter results and lifting its 2025 outlook, prompting multiple bullish calls from Wall Street. CLBT stock jumps as investors digest Q3 beat
13 November 2025
 ·  ·  ·  ·  · 
Sealed Air (SEE) Soars to 52‑Week High as Clayton Dubilier & Rice Weighs Take‑Private Deal

Sealed Air (SEE) Soars to 52‑Week High as Clayton Dubilier & Rice Weighs Take‑Private Deal

Sealed Air Corporation (NYSE: SEE), maker of Bubble Wrap, jumped to a 52‑week high on November 13, 2025, as private‑equity firm Clayton Dubilier & Rice reportedly explores a take‑private deal. Here’s what’s driving SEE stock today, including fresh buyout rumors,
13 November 2025
 ·  ·  ·  ·  · 
Outlook Therapeutics (OTLK) Soars as FDA Accepts ONS‑5010 BLA and Sets December 31, 2025 Review Date

Outlook Therapeutics (OTLK) Soars as FDA Accepts ONS‑5010 BLA and Sets December 31, 2025 Review Date

Outlook Therapeutics (NASDAQ: OTLK) shares jumped today after the U.S. FDA accepted the company’s resubmitted Biologics License Application (BLA) for ONS‑5010/LYTENAVA, its bevacizumab-based eye drug for wet AMD, and set a PDUFA review date of December 31, 2025. Here’s what
13 November 2025
 ·  ·  ·  ·  · 
Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Vancouver / Jerusalem – November 13, 2025 – Shares of Clearmind Medicine Inc. (NASDAQ: CMND), a clinical‑stage psychedelic and neuroplastogen biotech company, jumped sharply on Thursday after the firm announced final approval to expand its FDA‑regulated Phase 1/2a clinical trial
13 November 2025
 ·  ·  ·  ·  · 
Nebius (NBIS) Stock Slides After Q3 2025 Earnings: $3B Meta AI Deal, Microsoft Pact and CoreWeave Rivalry, Explained

Nebius (NBIS) Stock Slides After Q3 2025 Earnings: $3B Meta AI Deal, Microsoft Pact and CoreWeave Rivalry, Explained

Nebius Group (NASDAQ: NBIS) has just delivered one of the most dramatic weeks in the AI‑infrastructure trade: Today, November 13, Nebius shares are trading back in the high‑$80s, down around 6% intraday and more than 30% off recent highs near
13 November 2025
 ·  ·  ·  ·  ·  ·  · 
VisionSys AI (VSA) Crashes Nearly 78% After $12 Million Direct Offering as Shareholders Head Into High‑Stakes Vote

VisionSys AI (VSA) Crashes Nearly 78% After $12 Million Direct Offering as Shareholders Head Into High‑Stakes Vote

VisionSys AI Inc. (NASDAQ: VSA) has become one of Wall Street’s most talked‑about micro‑caps after its shares collapsed nearly 78% in a single session, wiping out most of its recent gains and putting fresh scrutiny on the company’s aggressive capital‑raising
13 November 2025
 ·  ·  ·  ·  · 
Rigetti Computing (RGTI) News Today – 13 November 2025: CEO’s $11 Million Trade, Short-Seller Pressure and Fresh Institutional Buying

Rigetti Computing (RGTI) News Today – 13 November 2025: CEO’s $11 Million Trade, Short-Seller Pressure and Fresh Institutional Buying

Rigetti Computing, Inc. (NASDAQ: RGTI) — one of the market’s most volatile quantum computing stocks — is back in the spotlight today, 13 November 2025, as new headlines hit around insider activity, short-seller scrutiny, fresh institutional buying, and the fallout
13 November 2025
 ·  ·  ·  ·  · 
TNL Mediagene (TNMG) Stock Explodes on Coupang Deal: What Today’s Partnership Means for Taiwan’s Content Commerce Boom – 13 November 2025

TNL Mediagene (TNMG) Stock Explodes on Coupang Deal: What Today’s Partnership Means for Taiwan’s Content Commerce Boom – 13 November 2025

TNL Mediagene (NASDAQ: TNMG) is back in the spotlight today after unveiling a strategic partnership with U.S. Fortune 150 technology and e‑commerce company Coupang, Inc. (NYSE: CPNG), focused on the fast‑growing Taiwan market. PR Newswire+2Coupang, Inc.+2 The Tokyo‑headquartered digital media
13 November 2025
 ·  ·  ·  ·  ·  · 
1 … 46 47 48 49 50 … 232
Go toTop